Background: This is the first comparison of two combination therapies, fluticasone
propionate/salmeterol and ipratropium bromide/albuterol (salbutamol), for the treatment of …

Study objectives: To compare the efficacy of adding formoterol or salbutamol to regular
ipratropium bromide treatment in COPD patients whose conditions were suboptimally …

This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …

Purpose To evaluate fluticasone propionate/formoterol (FP/FORM) in COPD. Patients and
methods COPD patients with forced expiratory volume in 1 s (FEV1)≤ 50% predicted and≥ …

Introduction: Airway inflammation is a known pathological feature of chronic obstructive
pulmonary disease (COPD). We examined the effect of inhaled salmeterol, alone and in …

Prevention and treatment of COPD exacerbations are recognized as key goals in disease
management. This randomized, double-blind, parallel-group, multicenter study evaluated …

In the present trial, we compared the broncholytic efficacy of the combination therapy with 50
μg salmeterol+ 250 μg fluticasone and 12 μg formoterol+ 400 μg budesonide, both in a …

Inhaled corticosteroids are often used in the treatment of stable chronic obstructive
pulmonary disease (COPD), however, studies of these agents have had mixed results …

Study objectives. The aim of this study was to compare the relative efficacy in terms of
improvement in symptoms and lung function of salmeterol/fluticasone propionate (SLM/FP) …

Background: β 2-Agonists andcorticosteroids or theophylline can interact to produce
beneficialeffects on airway function in asthma, but this has not been establishedin COPD …